You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Last Updated: December 7, 2023

Gland Pharma Ltd Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for GLAND PHARMA LTD, and what generic and branded alternatives to GLAND PHARMA LTD drugs are available?

GLAND PHARMA LTD has one hundred and three approved drugs.

There is one tentative approval on GLAND PHARMA LTD drugs.

Summary for Gland Pharma Ltd

US Patents:	0
Tradenames:	93
Ingredients:	88
NDAs:	103
Drug Master File Entries:	37

Drugs and US Patents for Gland Pharma Ltd

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Gland Pharma Ltd	VANCOMYCIN HYDROCHLORIDE	vancomycin hydrochloride	INJECTABLE;INJECTION	205694-001	Jan 21, 2016	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Gland Pharma Ltd	OCTREOTIDE ACETATE	octreotide acetate	INJECTABLE;INJECTION	216839-001	Jun 22, 2023	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Gland Pharma Ltd	PHENYLEPHRINE HYDROCHLORIDE	phenylephrine hydrochloride	SOLUTION;INTRAVENOUS	211920-002	Jun 5, 2020	AP1	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Gland Pharma Ltd	KETAMINE HYDROCHLORIDE	ketamine hydrochloride	INJECTABLE;INJECTION	216809-003	Jan 24, 2023	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Gland Pharma Ltd	KETOROLAC TROMETHAMINE	ketorolac tromethamine	INJECTABLE;INJECTION	076722-001	Jul 27, 2004		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Gland Pharma Ltd	KETAMINE HYDROCHLORIDE	ketamine hydrochloride	INJECTABLE;INJECTION	216809-002	Jan 24, 2023	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Gland Pharma Ltd	BIMATOPROST	bimatoprost	SOLUTION/DROPS;OPHTHALMIC	210126-001	Mar 22, 2019	AT	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for GLAND PHARMA LTD drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Injection	1 mg/mL, 50 mL vials	➤ Subscribe	2011-12-16
➤ Subscribe	Injection	100 mg/mL, 2.5 mL vials	➤ Subscribe	2007-09-24
➤ Subscribe	Injection	250 mcg/0.5 mL, 1 mL PFS	➤ Subscribe	2012-03-30

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic

Moodys

AstraZeneca

McKesson

Harvard Business School

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.